Meet the Faculty

Seema Arif is a Consultant Clinical Oncologist at Velindre Cancer Centre, Cardiff, UK, specialises in Upper and lower GI cancers and is lead local investigator for a number of clinical trials in these areas. She graduated from Jawaharlal Medical College in Belgaum, India and completed her post graduate training in the UK. She completed MRCP in Internal Medicine thereafter specialised in Oncology. Seema started her oncology career at the St Thomas’ Hospital, London followed by Western General Hospital, Edinburgh and completed her training in Velindre Cancer Centre, Cardiff. Seema did a Radiation Oncology Fellowship with Professor Brian O’Sullivan and Professor Bernard Cummings at the prestigious Princess Margaret Hospital, Toronto after which she took up a consultant post in Cardiff. Seema used these skills and knowledge to set up the first Liver SBRT clinical service in Wales.

Seema has completed a degree in Medical Education from Cardiff University. She has been a Cardiff FRCR Course faculty member since 2008 and has a keen interest in International Educational Collaboration, especially with India where her roots are from. She started the Cardiff FRCR 2 course International day which introduces UK cancer management pathways, communication and presentation skills to non- UK trainees taking the FRCR exam.

Seema’s connections and negotiations with TATA Medical Centre, Kolkata have been pivotal in the launch of the first Cardiff FRCR 2 course in India in May 2019. She is very keen to expand these International Educational Collaborations with TMC Kolkata in terms of Research, Fellowships & exchange Programmes and introducing communication skills in medical schools in India. She is presently clinical lead for the Moondance funded Advanced Radiotherapy Fellowship Programme at Velindre Cancer Centre.

Martin Rolles is a Clinical Oncologist specialising in Head & Neck Cancer, and Breast Cancer. He is the Cancer Lead for Swansea Bay University Health Board, and chair of the Wales Cancer Network Clinical Reference Group. He also chairs the Welsh Scientific Advisory Committee, and the All-Wales PBT, PET, and Molecular Radiotherapy Advisory Groups.

Martin sits on of the Council of the Royal College of Radiologists, and is a member of the RCR Equality Diversity and Inclusion (EDI) Committee.

After taking a degree in Zoology at the University of Bristol, Martin read medicine at the University of Wales, returning after specialist training in Wessex and Vancouver.

Dr Shaw is a Clinical Oncologist with previous experience in the treatment of UGI and Anal cancers, and latterly now focusses on Thoracic malignancies. Paul completed Specialist Training in Palliative Medicine in 2002 prior to training in Oncology in South  Wales, and enjoys combining this expertise in his daily practice. Paul was CRUK Bobby Moore Clinical Research Fellow in Prof Alan Clarkes lab 2006-2010 becoming familiar with genetically engineered models of cancer (PhD awarded) and subsequent 3D organoid technology. He has supervised a number of Cardiff University PhD students since this time most recently examining Drug RT combinations in NSCLC and immunological aspects of Mesothelioma. Paul is the clinical lead for Early Phase Drug Radiation studies at VUNHST and has been involved with CRUK sponsored trials in Oesophageal Cancer and is Co-Investigator for the CONCORDE platform study in NSCLC. He is Co-CI of the UK HITMESO trial studying the role of Proton therapy in pleural mesothelioma.

Dr Morgan is a clinical oncologist in Velindre Cancer centre with over 10 years’ experience specialising in the treatment of oesophagogastric cancer, neuroendocrine tumours and gastrointestinal stromal tumours with an particular interest in delivery of oesophageal chemoradiotherapy. Alongside her clinical work, she is upper GI cancer lead for the Wales Cancer Network currently focusing on UGI pathway improvement and equity of access to high quality research for patients in Wales.